HCAT
Health Catalyst·NASDAQ
--
--(--)
--
--(--)
4.41 / 10
Netural
Analyst sentiment is largely neutral (83% neutral, 17% strong‑buy) with mixed historical performance; Wells Fargo cut its rating to equal weight. Fund flow is positive (score 7.53) showing overall inflow, though small and medium blocks are weakening. The view remains cautious.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
17%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Date2026-03-13
InstitutionCitigroup
Times predicted5
Historical Win Rate20.0%
What is the market sentiment for HCAT?
- HCAT holds a Bearish analyst rating, with 17% of experts assigning a Strong Buy grade. Factoring in net Inflows from order flow data, the comprehensive Sentiment Score stands at 4.41/10 (Netural).
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
